PeterLabs Holdings Bhd (0171) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.107x

Based on the latest financial reports, PeterLabs Holdings Bhd (0171) has a cash flow conversion efficiency ratio of 0.107x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (RM8.43 Million ≈ $2.12 Million USD) by net assets (RM78.60 Million ≈ $19.73 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

PeterLabs Holdings Bhd - Cash Flow Conversion Efficiency Trend (2015–2024)

This chart illustrates how PeterLabs Holdings Bhd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read debt load of PeterLabs Holdings Bhd for a breakdown of total debt and financial obligations.

PeterLabs Holdings Bhd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of PeterLabs Holdings Bhd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Kps AG
XETRA:KSC
0.198x
SIXTY NORTH GOLD MIN.LTD.
F:2F40
-0.020x
ValOre Metals Corp
V:VO
-0.138x
DCM Limited
NSE:DCM
-0.037x
RLF Agtech Ltd
AU:RLF
-0.192x
Intersport Polska S.A.
WAR:IPO
0.401x
Moment Group AB
ST:MOMENT
-0.613x
Ihlas Ev Aletleri Imalat Sanayi ve Ticaret AS
IS:IHEVA
0.020x

Annual Cash Flow Conversion Efficiency for PeterLabs Holdings Bhd (2015–2024)

The table below shows the annual cash flow conversion efficiency of PeterLabs Holdings Bhd from 2015 to 2024. For the full company profile with market capitalisation and key ratios, see 0171 company net worth.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 RM76.94 Million
≈ $19.32 Million
RM12.39 Million
≈ $3.11 Million
0.161x +125.23%
2023-12-31 RM75.76 Million
≈ $19.02 Million
RM5.42 Million
≈ $1.36 Million
0.071x +4690.19%
2022-12-31 RM74.37 Million
≈ $18.67 Million
RM111.00K
≈ $27.87K
0.001x +102.28%
2021-12-31 RM72.42 Million
≈ $18.18 Million
RM-4.74 Million
≈ $-1.19 Million
-0.065x -139.00%
2020-12-31 RM58.36 Million
≈ $14.65 Million
RM9.78 Million
≈ $2.46 Million
0.168x -16.76%
2019-12-31 RM52.47 Million
≈ $13.17 Million
RM10.57 Million
≈ $2.65 Million
0.201x +519.97%
2018-12-31 RM48.26 Million
≈ $12.12 Million
RM1.57 Million
≈ $393.66K
0.032x -18.48%
2017-12-31 RM45.74 Million
≈ $11.48 Million
RM1.82 Million
≈ $457.68K
0.040x -81.09%
2016-12-31 RM39.43 Million
≈ $9.90 Million
RM8.31 Million
≈ $2.09 Million
0.211x +876.31%
2015-12-31 RM38.99 Million
≈ $9.79 Million
RM-1.06 Million
≈ $-265.73K
-0.027x --

About PeterLabs Holdings Bhd

KLSE:0171 Malaysia Drug Manufacturers - Specialty & Generic
Market Cap
$16.58 Million
RM66.05 Million MYR
Market Cap Rank
#25709 Global
#741 in Malaysia
Share Price
RM0.24
Change (1 day)
+0.00%
52-Week Range
RM0.21 - RM0.45
All Time High
RM0.45
About

PeterLabs Holdings Berhad, an investment holding company, engages in manufacturing, distribution, trading, and export of animal health and nutrition products in Malaysia and internationally. The company operates through three segments: Manufacturing, Trading, and Others. It offers biosecurity products and disinfectants, compound feed supplements, feed additives, nutritional premixes, pharmaceutic… Read more